• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Deregulation of IRF Menbers in Human Retroviral Infection

Research Project

Project/Area Number 08044259
Research Category

Grant-in-Aid for international Scientific Research

Allocation TypeSingle-year Grants
SectionJoint Research
Research InstitutionNagasaki University

Principal Investigator

MATSUYAMA Toshifumi  Nagasaki University, School of Medicine, Professor, 医学部, 教授 (30165922)

Co-Investigator(Kenkyū-buntansha) MAK Tak W  Ontario Cancer Institute, Division of Bioresearch, Professor, 生物研究部, 教授
IKAWA Yoji  Tokyo Medical and Dental University, Division of Medical Resatch, Professor, 医学系研究科, 教授 (40085618)
TAK W. Mak  オンタリオ癌研究所, 生物研究部, 教授
Project Period (FY) 1996 – 1997
Project Status Completed (Fiscal Year 1997)
Budget Amount *help
¥7,300,000 (Direct Cost: ¥7,300,000)
Fiscal Year 1997: ¥3,600,000 (Direct Cost: ¥3,600,000)
Fiscal Year 1996: ¥3,700,000 (Direct Cost: ¥3,700,000)
KeywordsHuman retroviral infection / Interferon / インターフェロン調節因子 / ヒトレトロウイルス / ATL / IRF / 遺伝子欠損マウス
Research Abstract

In this study, we focused on the role of Interferon Regulatory Factor ( IRF ) family members in retroviral infection. First we could demonstrate the essential role of LSIRF/IRF-4, an IRF member solely expressed in mature lymphocytes, in T and B function by the development of the gene targeted mouse. In this mutant mouse, the number of T and B lymphocytes is normal, but disable to mount proliferative responses against mitogens or anti-CD3 antibodies or alloantigens. In human, constitutive expression of LSIRF/lRF-4 is found only in cells infected with HTLV-1 , a causative agent of adult leukemia/lymphoma which is prevalent in our Nagasaki area. From clinical analysis, high-expression level is well correlated with the leukemic stage of the patients of ATL, suggesting the possible marker for prognosis in the disease as well as the role of the factor in leukemia as an oncogene. However, many efforts to clone a stable transformant with ectopically expressed LSIRF/lRF-4 is unsuccessful. Developing an inducible expression system of LSIRF/lRF-4, and isolating its associated factor (s) by yeast two-hybrid systems are now in progress.
In case of IRF-1 deficient mouse, poor development of NK cells and low expression of IL-1 5 was found. The latter caused by the defect of IRF-1 expression, at least in part, seems to contribute to the impairment of NK cells development. It is interesting to seek physiological conditions of low expression of IRF-1 , by which individuals are susceptible to viral infection in general. On the other hand, this mutant mouse is resistant to a experimental model of human multiple sclerosis, a disease suggestedly caused by retroviral infection, implying that individuals protect themselves against retroviral infection by induction of IRF-1 at the risk of some autoimmune disease involvement.

Report

(2 results)
  • 1997 Final Research Report Summary
  • 1996 Annual Research Report
  • Research Products

    (10 results)

All Other

All Publications (10 results)

  • [Publications] Penninger JM et al.: "The interferon-regulatory transcription factor IRF-1 controls positive and negative selection of CD8+ thymocytes. immunity, 7, 243-254, 1997"Immunity. 7. 245-254 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Tada Y et al.: "Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking IRF-1"Journal of Experimental Medicine. 185. 231-238 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Mittrucker HW et al.: "Requirment for the transcription factor LSIRF/IRF-4 for Mature B and TLymphocyte Function"Science. 257. 540-543 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Penninger JM, et al.: "The interferon regulatory transcription factor IRF-1 controls Positive and negative selection of CD8+ thymocytes"Immunity. 7. 243-254 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Tada Y, et al.: "Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking IRF-1"J. Exp. Med.. 185. 231-238 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Mittrucker HW: "Requirement for the transcription factor LSIRF/IRF-4 for mature B and T lymphocyte function"Science. 275. 540-543 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Mittrucker H. W., et al: "Requirement for the transcription factor LSIRF/IRF-4 for mature B and T lymphocyte function." Science. 275. 540-543 (1997)

    • Related Report
      1996 Annual Research Report
  • [Publications] Tada Y., et al: "Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking IRF-1" J. Exp. Med.185. 231-238 (1997)

    • Related Report
      1996 Annual Research Report
  • [Publications] Duncan GS., et al.: "The transcription facter interferon regulatory factor-1 is essential for natural killer cell function in vivo" J. Exp. Med.184. 2043-2048 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] Tanaka N., et al.: "Cooperation of the tumor suppressors IRF-1 and p53 in response to DNA damage" Nature. 382. 816-818 (1996)

    • Related Report
      1996 Annual Research Report

URL: 

Published: 1996-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi